WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ANGO past revenue growth

How has ANGO's revenue growth performed historically?
Company
-3.19%
Industry
7.75%
Market
16.96%
ANGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANGO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANGO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANGO earnings and revenue history

Current Revenue
$324.0M
Current Earnings
-$192.4M
Current Profit Margin
-59.4%

ANGO Return on Equity

Current Company
-54%
Current Industry
4.9%
Current Market
28.2%
ANGO's Return on Equity (-54%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ANGO announces earnings.

ANGO Return on Assets

Current Company
-41.6%
Current Industry
4.7%
ANGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANGO Return on Capital Employed

Current Company
-83.49%
Current Industry
7%
ANGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANGO vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANGO$324.01M-$169.01M-$192.37M+9.57%N/A
UTMD$50.22M$26.46M$16.64M+3.64%-1.62%
STXS$26.77M-$20.09M-$22.06M-1.82%N/A
SMTI$64.99M$190.58k-$4.30M+61.93%N/A
AKYA$96.63M-$45.63M-$63.32M+22.99%N/A
View Top Medical Stocks

Angiodynamics Earnings & Revenue FAQ

What were ANGO's earnings last quarter?

On Invalid Date, Angiodynamics (NASDAQ: ANGO) reported Q1 2024 earnings per share (EPS) of -$4.67, up 1,845.83% year over year. Total Angiodynamics earnings for the quarter were -$187.74 million. In the same quarter last year, Angiodynamics's earnings per share (EPS) was -$0.24.

If you're new to stock investing, here's how to buy Angiodynamics stock.

What was ANGO's earnings growth in the past year?

As of Q2 2024, Angiodynamics's earnings has grown year over year. Angiodynamics's earnings in the past year totalled -$192.37 million.

What was ANGO's revenue last quarter?

On Invalid Date, Angiodynamics (NASDAQ: ANGO) reported Q1 2024 revenue of $75.18 million up 6.85% year over year. In the same quarter last year, Angiodynamics's revenue was $80.71 million.

What was ANGO's revenue growth in the past year?

As of Q2 2024, Angiodynamics's revenue has grown -3.19% year over year. This is 10.94 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Angiodynamics's revenue in the past year totalled $324.01 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.